MoneyWorks4Me

Windlas Biotech - Quaterly Results

11 Aug 2026 Evaluate
The company witnessed a 18.09% growth in the revenue at Rs. 2480.99 millions for the quarter ended June 2026 as compared to Rs. 2100.90 millions during the year-ago period.The Net proft of the company remain more or less same to Rs. 176.53  millions from Rs. 176.65 millions ,decline by -0.07%.OP of the company witnessed a marginal growth to 317.92 millions from 317.63 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 2480.99 2100.90 18.09 2480.99 2100.90 18.09 9040.89 7598.78 18.98
Other Income 51.13 52.39 -2.41 51.13 52.39 -2.41 178.04 176.46 0.90
PBIDT 317.92 317.63 0.09 317.92 317.63 0.09 1224.99 1117.61 9.61
Interest 16.50 10.57 56.10 16.50 10.57 56.10 48.25 43.82 10.11
PBDT 301.42 307.06 -1.84 301.42 307.06 -1.84 1176.74 1073.79 9.59
Depreciation 72.06 74.48 -3.25 72.06 74.48 -3.25 307.43 279.85 9.86
PBT 229.36 232.58 -1.38 229.36 232.58 -1.38 869.31 793.94 9.49
TAX 52.83 55.93 -5.54 52.83 55.93 -5.54 204.96 187.45 9.34
Deferred Tax -10.71 0.40 -2777.50 -10.71 0.40 -2777.50 -2.03 4.72 -143.01
PAT 176.53 176.65 -0.07 176.53 176.65 -0.07 664.35 606.49 9.54
Equity 103.18 104.80 -1.55 103.18 104.80 -1.55 105.53 104.80 0.70
PBIDTM(%) 12.81 15.12 -15.24 12.81 15.12 -15.24 13.55 14.71 -7.88

Windlas Biotech Share Price

949.45 1.60 (0.17%)
14-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1924.90
Dr. Reddys Labs. 1202.00
Cipla 1450.00
Lupin 2235.00
Zydus Lifesciences 1140.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: